Taipei, Nov. 12 (CNA) Taiwan’s Food and Drug Administration (FDA) said Friday that buyers of Atomy Corp.’s HemoHIM honey drink should stop using it after it was found to contain methoxsalen, a medication that potentially causes liver damage.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

source

Shop Sephari